Gufic Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	157.23	11.37	286.02	116.08	62.01
Cash & Short-Term Investments	880.79	157.23	11.37	286.02	116.08	62.01
Cash Growth	354.12%	1283.12%	-96.03%	146.40%	87.18%	45.52%
Accounts Receivable	-	3,146	3,299	2,055	1,516	1,245
Other Receivables	-	15.71	-	-	-	-
Receivables	-	3,165	3,303	2,057	1,519	1,248
Inventory	-	2,169	2,005	1,835	1,156	944.05
Prepaid Expenses	-	13.11	8.61	9.5	8.51	5.8
Other Current Assets	-	741.2	676.9	454.29	407.93	346.43
Total Current Assets	-	6,245	6,005	4,641	3,208	2,606
Property, Plant & Equipment	-	5,215	4,603	3,285	1,554	1,129
Long-Term Investments	-	17.84	17.84	7.84	0.08	0.08
Other Intangible Assets	-	63.44	56.19	6.79	6.1	4.45
Long-Term Deferred Tax Assets	-	-	-	9.66	-	-
Other Long-Term Assets	-	150.33	239.13	658.02	443.58	178.1
Total Assets	-	11,694	10,925	8,612	5,214	3,921
Accounts Payable	-	1,587	1,663	1,303	1,410	1,112
Accrued Expenses	-	197.36	184.07	143.78	172.45	191.99
Short-Term Debt	-	1,543	1,420	1,118	65.99	163.24
Current Portion of Long-Term Debt	-	256.08	210.54	89.67	66.65	35.98
Current Portion of Leases	-	62.27	43.26	65.76	28.17	33.66
Current Income Taxes Payable	-	-	25.45	31.24	6.75	15.82
Other Current Liabilities	-	229.7	174.31	131.37	114.5	83.79
Total Current Liabilities	-	3,876	3,720	2,882	1,864	1,637
Long-Term Debt	-	1,305	1,540	1,907	479.78	354.27
Long-Term Leases	-	195.93	115.55	162.1	3.29	28.22
Pension & Post-Retirement Benefits	-	105.32	90.59	77.75	65.88	51.34
Long-Term Deferred Tax Liabilities	-	77.72	20.63	-	1.9	14.9
Other Long-Term Liabilities	-	123.34	112.92	104.8	107.98	100.9
Total Liabilities	-	5,683	5,600	5,134	2,523	2,186
Common Stock	-	100.28	100.28	96.95	96.95	96.95
Additional Paid-In Capital	-	996.57	996.57	-	-	-
Retained Earnings	-	4,223	3,538	2,686	1,899	950.31
Comprehensive Income & Other	-	690.49	690.72	694.76	695.22	687.11
Shareholders' Equity	6,312	6,011	5,326	3,478	2,691	1,734
Total Liabilities & Equity	-	11,694	10,925	8,612	5,214	3,921
Total Debt	3,692	3,362	3,329	3,342	643.87	615.37
Net Cash (Debt)	-2,811	-3,205	-3,318	-3,056	-527.79	-553.36
Net Cash Per Share	-28.02	-31.96	-33.68	-31.52	-5.44	-5.71
Filing Date Shares Outstanding	100.19	100.28	100.28	96.94	96.94	96.94
Total Common Shares Outstanding	100.19	100.28	100.28	96.94	96.94	96.94
Working Capital	-	2,370	2,284	1,759	1,344	969.2
Book Value Per Share	63.02	59.94	53.11	35.88	27.76	17.89
Tangible Book Value	6,249	5,947	5,269	3,471	2,685	1,730
Tangible Book Value Per Share	62.40	59.31	52.55	35.81	27.70	17.84
Land	-	103.9	98.9	-	-	-
Buildings	-	1,230	383.55	417.59	355.81	235.49
Machinery	-	4,167	1,516	1,534	1,229	1,119
Construction In Progress	-	218.16	3,071	1,696	408.74	134.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.